Twenty Years of Lyme Borreliosis in the Netherlands: Temporal Trends in Seroprevalence and Risk Factors

Overview

Journal Microorganisms

Specialty Microbiology

Date 2024 Nov 27

PMID 39597574

Authors

B J A Hoeve-Bakker

Oda E van den Berg

H S Doppenberg

Fiona R M van der Klis

Cees C van den Wijngaard

Jan A J W Kluytmans

Steven F T Thijsen

Karen Kerkhof

Affiliations

Soon will be listed here.

Abstract

Lyme borreliosis (LB) is not notifiable in many European countries, and the patchwork of surveillance strategies in Europe perpetuates knowledge gaps. In the Netherlands, LB incidence has been estimated from recurring general practitioner surveys since the 1990s. To complement the incidence data, this study aimed to estimate the prevalence of antibodies against sensu lato in the general population of the Netherlands in 1995/1996, identify risk factors for seropositivity, and compare these findings to data from 2016/2017 to identify temporal trends. Sera from participants (n = 8041, aged 0-80 years) in a cross-sectional nationwide surveillance study were assessed for the presence of antibodies against s.l., using a screening ELISA and immunoblot confirmation. Risk factors associated with seropositivity were evaluated using multivariable analysis. A significant difference in weighted seroprevalence was observed between 1995/1996 (2.8%) and 2016/2017 (4.3%). In both cohorts, the seroprevalence was significantly higher among men than among women, and increased with age and tick bite frequency. The upward trend in age-specific seropositivity in individuals over 50 was steeper in 2016/2017 than in 1995/1996, possibly due to improved fitness among contemporary elderly, allowing increased outdoor activities. This study highlights significant trends in the seroprevalence of s.l. antibodies in the general population of the Netherlands over 20 years. The doubling of seroprevalence underscores the increasing burden of LB, and the importance of continued surveillance. Targeted interventions, particularly for elderly populations, may help raise awareness to the risks of tick bites and reduce the growing disease burden and societal costs associated with LB.

References

Hoeve-Bakker B, Kerkhof K, Heron M, Thijsen S, van Gorkom T . Evaluation of different standard and modified two-tier testing strategies for the laboratory diagnosis of lyme borreliosis in a European setting. Eur J Clin Microbiol Infect Dis. 2024; 43(12):2397-2406. PMC: 11608311. DOI: 10.1007/s10096-024-04956-y. View

Hofhuis A, Harms M, van den Wijngaard C, Sprong H, van Pelt W . Continuing increase of tick bites and Lyme disease between 1994 and 2009. Ticks Tick Borne Dis. 2014; 6(1):69-74. DOI: 10.1016/j.ttbdis.2014.09.006. View

Dard C, Bailly S, Drouet T, Fricker-Hidalgo H, Brenier-Pinchart M, Pelloux H . Long-term sera storage does not significantly modify the interpretation of toxoplasmosis serologies. J Microbiol Methods. 2017; 134:38-45. DOI: 10.1016/j.mimet.2017.01.003. View

Verberk J, Vos R, Mollema L, van Vliet J, van Weert J, de Melker H . Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands. BMC Infect Dis. 2019; 19(1):470. PMC: 6537387. DOI: 10.1186/s12879-019-4019-y. View

Vos E, Den Hartog G, Schepp R, Kaaijk P, van Vliet J, Helm K . Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave. J Epidemiol Community Health. 2020; . PMC: 8142429. DOI: 10.1136/jech-2020-215678. View

Houben E, de Jong H, Penning-van Beest F, Kuiper J, Holthuis E, Blum M . Incidence of Lyme Borreliosis in the Dutch General Practice Population: A Large-Scale Population-Based Cohort Study Across the Netherlands Between 2015 and 2019. Vector Borne Zoonotic Dis. 2023; 23(4):230-236. PMC: 10122225. DOI: 10.1089/vbz.2022.0048. View

Stanek G, Strle F . Lyme borreliosis-from tick bite to diagnosis and treatment. FEMS Microbiol Rev. 2018; 42(3):233-258. DOI: 10.1093/femsre/fux047. View

Sprong H, Hofhuis A, Gassner F, Takken W, Jacobs F, van Vliet A . Circumstantial evidence for an increase in the total number and activity of Borrelia-infected Ixodes ricinus in the Netherlands. Parasit Vectors. 2012; 5:294. PMC: 3562265. DOI: 10.1186/1756-3305-5-294. View

Cuellar J, Dub T, Sane J, Hytonen J . Seroprevalence of Lyme borreliosis in Finland 50 years ago. Clin Microbiol Infect. 2019; 26(5):632-636. DOI: 10.1016/j.cmi.2019.10.003. View

10.

de Melker H, Conyn-Van Spaendonck M . Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect. 1999; 121(3):637-43. PMC: 2809572. DOI: 10.1017/s0950268898001587. View

11.

Burn L, Vyse A, Pilz A, Tran T, Fletcher M, Angulo F . Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005-2020). Vector Borne Zoonotic Dis. 2023; 23(4):172-194. PMC: 10122234. DOI: 10.1089/vbz.2022.0070. View

12.

Hoeve-Bakker B, Berg O, Doppenberg H, van der Klis F, van den Wijngaard C, Kluytmans J . Seroprevalence and Risk Factors of Lyme Borreliosis in The Netherlands: A Population-Based Cross-Sectional Study. Microorganisms. 2023; 11(4). PMC: 10143428. DOI: 10.3390/microorganisms11041081. View

13.

van den Wijngaard C, Hofhuis A, Simoes M, Rood E, van Pelt W, Zeller H . Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. Euro Surveill. 2017; 22(27). PMC: 5508331. DOI: 10.2807/1560-7917.ES.2017.22.27.30569. View

14.

van Gorkom T, Kremer K, Voet W, Notermans D, Vlaminckx B, Sankatsing S . Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective study. Eur J Clin Microbiol Infect Dis. 2017; 36(11):2137-2146. PMC: 5653717. DOI: 10.1007/s10096-017-3037-1. View

15.

Baarsma M, Schellekens J, Meijer B, Brandenburg A, Souilljee T, Hofhuis A . Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease. Eur J Clin Microbiol Infect Dis. 2020; 39(11):2143-2152. PMC: 7561539. DOI: 10.1007/s10096-020-03946-0. View

16.

Jurke A, Bannert N, Brehm K, Fingerle V, Kempf V, Kompf D . Serological survey of Bartonella spp., Borrelia burgdorferi, Brucella spp., Coxiella burnetii, Francisella tularensis, Leptospira spp., Echinococcus, Hanta-, TBE- and XMR-virus infection in employees of two forestry enterprises in North.... Int J Med Microbiol. 2015; 305(7):652-62. DOI: 10.1016/j.ijmm.2015.08.015. View

17.

Hofhuis A, Bennema S, Harms M, van Vliet A, Takken W, van den Wijngaard C . Decrease in tick bite consultations and stabilization of early Lyme borreliosis in the Netherlands in 2014 after 15 years of continuous increase. BMC Public Health. 2016; 16:425. PMC: 4877959. DOI: 10.1186/s12889-016-3105-y. View

18.

Woudenberg T, Bohm S, Bohmer M, Katz K, Willrich N, Stark K . Dynamics of -Specific Antibodies: Seroconversion and Seroreversion between Two Population-Based, Cross-Sectional Surveys among Adults in Germany. Microorganisms. 2020; 8(12). PMC: 7761102. DOI: 10.3390/microorganisms8121859. View

19.

Hofhuis A, van de Kassteele J, Sprong H, van den Wijngaard C, Harms M, Fonville M . Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model. PLoS One. 2017; 12(7):e0181807. PMC: 5524385. DOI: 10.1371/journal.pone.0181807. View

20.

van der Klis F, Mollema L, Berbers G, de Melker H, Coutinho R . Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009; 67(7):301-8. View